IXICO plc IXICO chosen for new Medical Imaging & AI Centre
March 01 2019 - 1:01AM
RNS Non-Regulatory
TIDMIXI
IXICO plc
01 March 2019
1(st) March 2019
IXICO plc
("IXICO" or the "Company")
IXICO chosen as partner for new Government funded Medical
Imaging & Artificial Intelligence Centre
Led by King's College London, the centre aims to leverage UK
research to improve the patient journey using artificial
intelligence
IXICO plc (AIM: IXI), the data analytics company delivering
insights in neuroscience, is delighted to announce that it has been
chosen as a small-to-medium enterprise (SME) partner in the newly
established London Medical Imaging & Artificial Intelligence
Centre for Value-Based Healthcare. With the official public launch
having taken place yesterday (28th February), the centre has been
established as part of the UK Government's Industrial Strategy
Challenge Fund. Led by King's College London, the new Centre will
develop and train sophisticated artificial intelligence (AI)
algorithms from NHS medical images and patient data to provide
tools for clinicians to speed up and improve diagnosis and care
across a number of patient pathways including dementia, heart
failure and cancer.
In order to achieve these results, the Centre brings together an
ambitious consortium including London universities, NHS Trusts,
industry partners including global multinationals and UK-based
SME's and the Health Innovation Network.
The Centre will have a focus on transformation and value-based
healthcare, and how advanced imaging and AI technologies can be
used to improve the patient journey. In addition to government
funding, the consortia partners have also made significant
investments to leverage UK research strengths and clinical
knowledge into becoming a leading industrial player in AI and
healthcare. IXICO will contribute its expertise in neuroimaging and
data analysis and benefit from leveraging the centre's unique
infrastructure and collaborative framework to accelerate
development of its innovative AI analytics solutions to support
improved decision-making in neuroscience clinical development.
Giulio Cerroni, Chief Executive of IXICO, said: "We are excited
to be selected to be part of this flagship UK Government initiative
to ensure that UK science is at the forefront of the application
and impact of Artificial Intelligence to the future of healthcare.
The development and application of artificial intelligence
technology will enable IXICO to develop highly valued, innovative
solutions to our biopharmaceutical clients in support of their
neuroscience clinical development programmes. We are looking
forward to collaborations with other leaders across this expanding
field of research."
For further information please contact:
IXICO plc
Giulio Cerroni, Chief Executive Officer Tel: +44 20 3763
7498
FTI Consulting Limited (Investor Relations)
Simon Conway / Victoria Foster Mitchell / Tel: +44 20 3727
Tim Stamper 1000
About IXICO
IXICO is dedicated to delivering insights in neuroscience. Our
mission is to transform the progression of our biopharmaceutical
clients' neurological therapeutic pipelines through the application
of novel medical imaging and mobile health digital
technologies.
IXICO's data analytics services are used by the global
biopharmaceutical industry to interpret data from brain scans and
digital biosensors to enable better trial design, site
qualification, patient selection and clinical outcomes. We provide
technology-enabled services across all phases of clinical
evaluation. Our integrated digital platform provides a scalable and
secure infrastructure for the capture and analysis of regulatory
compliant clinical data to enable clients to make rapid, better
informed decisions. IXICO is also collaborating with partners to
develop new analytical techniques and companion digital health
products targeted at improving patient outcomes.
More information is available on www.IXICO.com
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
NRAKMGZZVRNGLZM
(END) Dow Jones Newswires
March 01, 2019 02:01 ET (07:01 GMT)
Ixico (LSE:IXI)
Historical Stock Chart
From Apr 2024 to May 2024
Ixico (LSE:IXI)
Historical Stock Chart
From May 2023 to May 2024